Most pharmacologically relevant genetic variants result in dramatic differences in gene product function or expression (complete loss of function, substantial increase in expression, etc). As a consequence, they have a major effect on the pharmacokinetic or pharmacodynamic properties of a drug. This is illustrated by
TPHT ACTIVITE (umts/ml RBC)
Was this article helpful?